IIROC Trade Resumption - EPRX.WT.A

About this update from Eupraxia Pharmaceuticals, Inc.

[{"type":"text","content":"\n \n \n \n IIROC Trade Resumption - EPRX.WT.A\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n TORONTO\n \n ,\n \n April 20, 2022\n \n /CNW/ - Trading resumes in:\n \n \n Company: Eupraxia Pharmaceuticals Inc.\n \n \n TSX Symbol: EPRX.WT.A\n \n \n All Issues: No\n \n \n Resumption (ET):\n \n 9:30 AM\n \n \n \n IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in\n \n Canada\n \n .\n \n \n SOURCE Investment Industry Regulatory Organization of\n \n Canada\n \n (IIROC) - Halts/Resumptions\n \n \n \n \n \n \n View original content:\n \n http://www.newswire.ca/en/releases/archive/April2022/20/c7149.html\n \n \n \n \n\n","length":2285,"tagName":"div"}]

More updates from Eupraxia Pharmaceuticals, Inc.